How to Remove Smoke Odor from Your Home?
I am sure this might annoy you big time. You might feel nauseous at times too when your smell this strong smoke odor. You might want to get rid of this nasty habit of your family member but you are…
独家优惠奖金 100% 高达 1 BTC + 180 免费旋转
Biopharmaceuticals Contract Manufacturing Market Segmentation
Biopharmaceuticals Contract Manufacturing Market Growth & Trends
The reliance of companies on CMOs for the production of biologics and biosimilars is expected to rise during the forecast period as a consequence of changes adopted by the CMOs. This is evident through growing investment in collaborations of companies with CMOs as well as continuous efforts taken up for expanding the service portfolio. The supply chain of biopharmaceuticals remained robust and was largely unaffected worldwide during the coronavirus outburst. Also, biopharmaceutical contract manufacturers are observing increased demand related to COVID-19 vaccine and therapeutics. Thus, the future holds numerous opportunities for the market. For instance, in 2020, AstraZeneca and Oxford Biomedica signed a one-year clinical and commercial supply agreement for the manufacturing of AstraZeneca’s COVID-19 vaccine candidate, AZD1222.
Browse full report with Table of Content (PDF with All Related Graph and Chart)@
Biopharmaceuticals Contract Manufacturing Market Report Highlights
· Mammalian-based biopharmaceutical contract manufacturing captured the largest market share about 58% in 2021 owing to the high penetration of mammalian expression systems for biologics development
· Out of all the services offered in this market, process development contributed to the largest share of 33% in 2021, owing to high capital investment, especially in downstream process
· Biologics contract manufacturing dominated its counterpart segment owing to higher demand for biologics production. However, the biosimilar segment is growing with a lucrative CAGR of 8.3% due to cost-saving advantages associated with biosimilars development
· The presence of an effective regulatory framework for biologics development in the U.S. has resulted in a large share of the North America market of 34.0% in 2021
· However, Asia Pacific is expected to emerge as the fastest-growing regional market with a CAGR of 5.8% from 2022 to 2030, owing to developing economies such as India and China incorporating developments to sustain the competition
Grand View Research has segmented the global biopharmaceuticals contract manufacturing market based on source, service, product, therapeutic area and region:
Biopharmaceuticals Contract Manufacturing Source Outlook (Revenue, USD Million, 2017–2030)
· Mammalian
· Non-mammalian
Biopharmaceuticals Contract Manufacturing Service Outlook (Revenue, USD Million, 2017–2030)
· Process Development
o Downstream
o Upstream
· Fill & Finish Operations
· Analytical & QC studies
· Packaging
Biopharmaceuticals Contract Manufacturing Product Outlook (Revenue, USD Million, 2017–2030)
· Biologics
o Monoclonal antibodies (MABs)
o Recombinant Proteins
o Vaccines
o Antisense, RNAi, & Molecular Therapy
o Others
· Biosimilars
Biopharmaceuticals Contract Manufacturing Therapeutic Area Outlook (Revenue, USD Million, 2017–2030)
· Oncology
· Autoimmune Diseases
· Metabolic Diseases
· Cardiovascular Diseases
· Neurology
· Infectious Diseases
· Others
Biopharmaceuticals Contract Manufacturing Regional Outlook (Revenue, USD Million, 2017–2030)
· North America
o U.S.
o Canada
· Europe
o UK
o Germany
o France
o Italy
Spain
· Asia Pacific
o China
o India
o Japan
o Australia
o South Korea
· Latin America
o Brazil
o Colombia
o Mexico
o Argentina
· Middle East & Africa
o South Africa
o Saudi Arabia
UAE
List of Key Players in Biopharmaceuticals Contract Manufacturing Market
· Boehringer Ingelheim GmbH
· Lonza
· Inno Biologics Sdn Bhd
· Rentschler Biotechnologie GmbH
· JRS PHARMA
· AGC Biologics
· ProBioGen
· FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
· Toyobo Co. Ltd.
· Samsung BioLogics
· Thermo Fisher Scientific, Inc.
· Binex Co., Ltd.
· WuXi Biologics
· AbbVie, Inc.
· Novartis AG
· ADMA Biologics, Inc.
· Catalent, Inc
· Cambrex Corporation
· Pfizer Inc.
· Siegfried Holding AG
About Grand View Research
Grand View Research is a full-time market research and consulting company registered in San Francisco, California. The company fully offers market reports, both customized and syndicates, based on intense data analysis. It also offers consulting services to business communities and academic institutions and helps them understand the global and business scenario to a significant extent. The company operates across multitude of domains such as Chemicals, Materials, Food and Beverages, Consumer Goods, Healthcare, and Information Technology to offer consulting services.
Related posts:
DAERAH ISTIMEWA YOGYAKARTA
Ada museum abadi yang disimpan dalam ingatan setiap orang.. “DAERAH ISTIMEWA YOGYAKARTA” is published by Deri Taufiq.